28May 2024
Inflammatory Markers Key Predictors of Survival in Diabetic Cancer Patients

Inflammatory Markers Key Predictors of Survival in Diabetic Cancer Patients

In this study, the relationship between inflammation, diabetes, and cancer was explored using data from the National Health and Nutrition Examination Survey (1999-2020). Four immune-related markers were examined to predict overall survival (OS) in diabetic cancer patients. The systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio were found to significantly predict OS (p < 0.05). Even after adjusting for confounders, these markers maintained predictive value. Non-linear relationships between inflammatory markers and OS were also observed. These findings highlight the prognostic potential of inflammatory markers in diabetic cancer patients, aiding in risk assessment.

  • #endo-diabetology

Like

Save

Share